Medical financial hardship among cancer survivors in the United States

被引:121
作者
Zheng, Zhiyuan [1 ]
Jemal, Ahmedin [1 ]
Han, Xuesong [1 ]
Guy, Gery P., Jr. [2 ]
Li, Chunyu [2 ]
Davidoff, Amy J. [3 ]
Banegas, Matthew P. [4 ]
Ekwueme, Donatus U. [2 ]
Yabroff, K. Robin [1 ]
机构
[1] Amer Canc Soc, Surveillance & Hlth Serv Res Program, Atlanta, GA 30303 USA
[2] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA
[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[4] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA
关键词
benefit design; cancer survivors; health insurance; medical financial hardship; 2ND PRIMARY CANCERS; COST COMMUNICATION; ECONOMIC BURDEN; CARE; ADULTS; PROJECTIONS; BANKRUPTCY; ADHERENCE; TOXICITY; SAMPLE;
D O I
10.1002/cncr.31913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The current study examined medical financial hardship in cancer survivors and those without a cancer history in the United States. Methods The 2013 to 2016 National Health Interview Survey was used to identify cancer survivors (stratified by ages 18-49 years [1424 survivors], ages 50-64 years [2916 survivors], and ages >= 65 years [6014 survivors]) and individuals without a cancer history (ages 18-64 years [66,951 individuals], ages 50-64 years [31,741 individuals], and ages >= 65 years [25,744 individuals]). Medical financial hardship was categorized into 3 domains: 1) material (eg, problems paying medical bills); 2) psychological (eg, worrying about paying medical bills); and 3) behavioral (eg, delaying/forgoing care due to cost). Generalized ordinal logistic regressions were used to examine the associations between cancer history, hardship, and health insurance deductibles/health savings accounts (among privately insured cancer survivors aged 18-64 years only). Results Compared with those without a cancer history, cancer survivors were more likely to report any material (ages 18-49 years: 43.4% vs 30.1%; ages 50-64 years: 32.8% vs 27.8%; and ages >= 65 years: 17.3% vs 14.7%), psychological (ages 18-49 years: 53.5% vs 47.1%), and behavioral (ages 18-49 years: 30.6% vs 21.8%; and ages 50-64 years: 27.2% vs 23.4%) measure of financial hardship, and multiple domains of hardship (age groups 18-49 years and 50-64 years; all P < .01). Among privately insured survivors, having a high-deductible health plan without a health savings account was found to be associated with greater hardship compared with having low-deductible insurance. Conclusions Younger cancer survivors are particularly vulnerable to material, psychological, and behavioral medical financial hardship. Interventions designed to reduce financial hardship should consider multiple domains of hardship as well as insurance benefit design.
引用
收藏
页码:1737 / 1747
页数:11
相关论文
共 54 条
  • [1] The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
    Abboud, Camille
    Berman, Ellin
    Cohen, Adam
    Cortes, Jorge
    DeAngelo, Daniel
    Deininger, Michael
    Devine, Steven
    Druker, Brian
    Fathi, Amir
    Jabbour, Elias
    Jagasia, Madan
    Kantarjian, Hagop
    Khoury, Jean
    Laneuville, Pierre
    Larson, Richard
    Lipton, Jeffrey
    Moore, Joseph O.
    Mughal, Tariq
    O'Brien, Susan
    Pinilla-Ibarz, Javier
    Quintas-Cardama, Alfonso
    Radich, Jerald
    Reddy, Vishnu
    Schiffer, Charles
    Shah, Neil
    Shami, Paul
    Silver, Richard T.
    Snyder, David
    Stone, Richard
    Talpaz, Moshe
    Tefferi, Ayalew
    Van Etten, Richard A.
    Wetzler, Meir
    Abruzzese, Elisabetta
    Apperley, Jane
    Breccia, Massimo
    Byrne, Jenny
    Cervantes, Francisco
    Chelysheva, Ekaterina
    Clark, R. E.
    de Lavallade, Hugues
    Dyagil, Iryna
    Gambacorti-Passerini, Carlo
    Goldman, John
    Haznedaroglu, Ibrahim
    Hjorth-Hansen, Henrik
    Holyoake, Tessa
    Huntly, Brian
    le Coutre, Philipp
    Lomaia, Elza
    [J]. BLOOD, 2013, 121 (22) : 4439 - 4442
  • [2] Financial Hardships Experienced by Cancer Survivors: A Systematic Review
    Altice, Cheryl K.
    Banegas, Matthew P.
    Tucker-Seeley, Reginald D.
    Yabroff, K. Robin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02):
  • [3] [Anonymous], 2016, HLTH AFFAIRS BLOG, DOI 10.1377/hblog20160205.053022.
  • [4] [Anonymous], 2017, SURV DESCR NAT HLTH
  • [5] For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships
    Banegas, Matthew P.
    Guy, Gery P., Jr.
    de Moor, Janet S.
    Ekwueme, Donatus U.
    Virgo, Katherine S.
    Kent, Erin E.
    Nutt, Stephanie
    Zheng, Zhiyuan
    Rechis, Ruth
    Yabroff, K. Robin
    [J]. HEALTH AFFAIRS, 2016, 35 (01) : 54 - 61
  • [6] National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008
    Bernard, Didem S. M.
    Farr, Stacy L.
    Fang, Zhengyi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) : 2821 - 2826
  • [7] Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence
    Bestvina, Christine M.
    Zullig, Leah L.
    Rushing, Christel
    Chino, Fumiko
    Samsa, Gregory P.
    Altomare, Ivy
    Tulsky, James
    Ubel, Peter
    Schrag, Deborah
    Nicolla, Jon
    Abernethy, Amy P.
    Peppercorn, Jeffrey
    Zafar, S. Yousuf
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (03) : 162 - +
  • [8] Cohen RA, 2016, CREDIBLE STAT FINANC
  • [9] Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National Estimates
    Davidoff, Amy J.
    Guy, Gery P., Jr.
    Hu, Xin
    Gonzales, Felisa
    Han, Xuesong
    Zheng, Zhiyuan
    Parsons, Helen
    Ekwueme, Donatus U.
    Jemal, Ahmedin
    [J]. MEDICAL CARE, 2018, 56 (03) : 220 - 227
  • [10] The Development of a Financial Toxicity Patient-Reported Outcome in Cancer The COST Measure
    de Souza, Jonas A.
    Yap, Bonnie J.
    Hlubocky, Fay J.
    Wroblewski, Kristen
    Ratain, Mark J.
    Cella, David
    Daugherty, Christopher K.
    [J]. CANCER, 2014, 120 (20) : 3245 - 3253